Clinical Trial Update: Mitoxantrone, Etoposide, and Vinorelbine As Second-Line Therapy in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated a combination of mitoxantrone, etoposide, and vinorelbine as second-line therapy for metastatic prostate cancer that progress…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Navelbine (vinorelbine)
• Novantrone (mitoxantrone)
• VePesid (etoposide)

Snippet

Sponsor: Groupe D'Etude des Tumeurs Uro-Genitales | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED